Barclays raised the firm’s price target on HCA Healthcare (HCA) to $445 from $390 and keeps an Overweight rating on the shares. The firm incorporated preliminary estimates of newly approved state directed payments in Texas and updated price targets across the healthcare facilities and managed care group.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HCA:
- HCA Healthcare price target raised to $430 from $375 at BofA
- HCA Healthcare price target raised to $417 from $404 at Bernstein
- Balanced Outlook on HCA Healthcare: Strong Margins Amid Slower Growth and Policy Risks
- HCA Healthcare price target raised to $423 from $380 at Baird
- HCA Healthcare’s Earnings Call: Strong Growth Amid Challenges